|
SLC5A3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.615650E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.430300E-02 |
| Normal-vs-Stage2 |
8.758300E-02 |
| Normal-vs-Stage3 |
7.961900E-03 |
| Normal-vs-Stage4 |
2.482500E-03 |
| Stage1-vs-Stage2 |
8.391400E-01 |
| Stage1-vs-Stage3 |
3.779200E-01 |
| Stage1-vs-Stage4 |
1.632820E-01 |
| Stage2-vs-Stage3 |
6.844600E-01 |
| Stage2-vs-Stage4 |
3.583600E-01 |
| Stage3-vs-Stage4 |
4.612400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.059000E-03 |
| Normal-vs-AfricanAmerican |
3.051800E-01 |
| Normal-vs-Asian |
2.346300E-02 |
| Caucasian-vs-AfricanAmerican |
5.309000E-01 |
| Caucasian-vs-Asian |
8.708800E-01 |
| AfricanAmerican-vs-Asian |
5.112600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.843520E-03 |
| Normal-vs-Female |
4.248400E-02 |
| Male-vs-Female |
1.446400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.144190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.963860E-02 |
| Normal-vs-Age(61-80Yrs) |
1.280140E-03 |
| Normal-vs-Age(81-100Yrs) |
5.414400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.854600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.067800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.190200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.508420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.659000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.416000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.416220E-03 |
| Classical-VS-Follicular |
6.958800E-03 |
| Classical-VS-Other |
1.585590E-01 |
| Classical-VS-Normal |
1.505810E-01 |
| Tall-VS-Follicular |
7.585000E-01 |
| Tall-VS-Other |
4.794400E-01 |
| Tall-VS-Normal |
2.421800E-04 |
| Follicular-VS-Other |
5.554600E-01 |
| Follicular-VS-Normal |
6.249200E-04 |
| Other-VS-Normal |
2.533600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.360160E-02 |
| Normal-vs-N1 |
2.503400E-03 |
| N0-vs-N1 |
4.062200E-01 |
|
|
